AstraZeneca rejects latest Pfizer approach

Wow - AstraZeneca has rejected Pfizer's fresh £55.00 a share offer.

Now, I have to admit I didn't see that coming. I thought the raise would allow both companies to at least start talking and get an extension to the "put up or shut up" deadline.